Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic a/h1n1 2009

Viral Immunology

Volumn 26, Issue 5, 2013, Pages 314-321

  Gauger, Phillip C ^a,b   Loving, Crystal L ^a   Lager, Kelly M ^a   Janke, Bruce H ^b   Kehrli, Marcus E ^a   Roth, James A ^b   Vincent, Amy L ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N2; LUNG; NONHUMAN; PANDEMIC INFLUENZA; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SWINE; VACCINE ASSOCIATED ENHANCED RESPIRATORY DISEASE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, VIRAL; CROSS REACTIONS; CYTOKINES; GENETIC VARIATION; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H1N2 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; RESPIRATORY TRACT INFECTIONS; SWINE; SWINE DISEASES; VACCINATION;

EID: 84885673768     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0018     Document Type: Article

References (45)

1. Barbe F, Atanasova K, and Van Reeth K: Cytokines and acute phase proteins associated with acute swine influenza infection in pigs. Vet J 2010;187:48-53
2. Bruder D, Srikiatkhachorn A, and Enelow RI: Cellular immunity and lung injury in respiratory virus infection. Viral Immunol 2006;19:147-155
3. Charerntantanakul W, and Roth JA: Biology of porcine T lymphocytes. Anim Health Res Rev 2006;7:81-96
4. Fazekas de SG, and Webster RG: Disquisitions of original antigenic sin. I. Evidence in man. J Exp Med 1966;124:331-345
5. Fazekas de SG, and Webster RG: Disquisitions on original antigenic sin. II. Proof in lower creatures. J Exp Med 1966; 124:347-361
6. Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME, Jr., and Roth JA: Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs With vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet Pathol 2012;49:900-912
7. Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr., and Roth JA: Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 2011;29:2712-2719
8. Gross PA, and Davis AE: Neutralization test in influenza: Use in individuals without hemagglutination inhibition antibody. J Clin Microbiol 1979;10:382-384
9. Haaheim LR: Original antigenic sin. A confounding issue? Dev Biol (Basel) 2003;115:49-53
10. Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, and Bianchi AT: Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol 2002;83:1851-1859
11. Heinen PP, van Nieuwstadt AP, Pol JM, de Boer-Luijtze EA, van Oirschot JT, and Bianchi AT: Systemic and mucosal isotype-specific antibody responses in pigs to experimental influenza virus infection. Viral Immunol 2000;13:237-247
12. Janjua NZ, Skowronski DM, Hottes TS, et al.: Seasonal influenza vaccine and increased risk of pandemic A/H1N1- related illness: First detection of the association in British Columbia, Canada. Clin Infect Dis 2010;51:1017-1027
13. Jo SK, Kim HS, Cho SW, and Seo SH: Pathogenesis and inflammatory responses of swine H1N2 influenza viruses in pigs. Virus Res 2007;129:64-70
14. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, and Matikainen S: Inflammatory responses in influenza A virus infection. Vaccine 2000;19:S32-S37
15. Karasin AI, Carman S, and Olsen CW: Identification of human H1N2 and human-swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005). J Clin Microbiol 2006;44:1123-1126
16. Kim JH, Skountzou I, Compans R, and Jacob J: Original antigenic sin responses to influenza viruses. J Immunol 2009;183:3294-3301
17. Kitikoon P, Vincent AL, Gauger PC, et al.: Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol 2012;86:6804-6814
18. Kitikoon P, Vincent AL, Janke BH, Erickson B, Strait EL, Yu S, Gramer MR, and Thacker EL: Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates. Vaccine 2009;28:523-531
19. Larsen DL, Karasin A, Zuckermann F, and Olsen CW: Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet Microbiol 2000;74:117-131
20. Lorusso A, Vincent AL, Harland ML, et al.: Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J Gen Virol 2011;92:919-930
21. Ma W, Lager KM, Lekcharoensuk P, Ulery ES, Janke BH, Solorzano A, Webby RJ, Garcia-Sastre A, and Richt JA: Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses. J Gen Virol 2010;91:2314-2321
22. Ma W, Lager KM, Vincent AL, Janke BH, Gramer MR, and Richt JA: The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 2009;56:326-337
23. Monsalvo AC, Batalle JP, Lopez MF, et al.: Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 2011;17:195-199
24. Moore KW, de Waal MR, Coffman RL, and O?Garra A: Interleukin- 10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765
25. Nelson MI, Vincent AL, Kitikoon P, Holmes EC, and Gramer MR: Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J Virol 2012;86:8872-8878
26. Opriessnig T, Yu S, Gallup JM, et al.: Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol 2003;40:521-529
27. Pena L, Vincent AL, Ye J, et al.: Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 2011;85:456-469
28. Platt R, Vincent AL, Gauger PC, Loving CL, Zanella EL, Lager KM, Kehrli ME Jr., Kimura K, and Roth JA: Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs. Vet Immunol Immunopathol 2011;142:252-257
29. Roth JA, Thacker EL: Immune System. In: Diseases of Swine. (Straw BE, Zimmerman JJ, D?Allaire S, Taylor DJ, eds). 9th ed. Blackwell Publishing, Ames, 2006, p. 15-36
30. Skowronski DM, De Serres G, Crowcroft NS, et al.: Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: Four observational studies from Canada. PLoS Med 2010;7:1-15
31. Strait EL, Madsen ML, Minion FC, Christopher-Hennings J, Dammen M, Jones KR, and Thacker EL: Real-time PCR assays to address genetic diversity among strains of Mycoplasma hyopneumoniae. J Clin Microbiol 2008;46:2491-2498
32. To KK, Zhang AJ, Hung IF, et al.: High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Clin Vaccine Immunol 2012;19:1012-1018
33. Van Reeth K: Cytokines in the pathogenesis of influenza. Vet Microbiol 2000;74:109-116
34. Van Reeth K, Labarque G, Nauwynck H, and Pensaert M: Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: Correlations with pathogenicity. Res Vet Sci 1999;67:47-52
35. Van Reeth K, Labarque G, and Pensaert M: Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses. Viral Immunol 2006;19:373-382
36. Van Reeth K, Nauwynck H, and Pensaert M: Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin- 1, and inflammation during acute influenza in pigs: A possible model for humans? J Infect Dis 1998;177: 1076-1079
37. Van Reeth K, Van GS, and Pensaert M: Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccinationimmune pigs. Viral Immunol 2002;15:583-594
38. Van Reeth K., Van GS, and Pensaert M: Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype. Vet Rec 2003; 153:9-13
39. Van Reeth KV, Brown I, Essen S, and Pensaert M: Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Virus Res 2004;103:115-124
40. Vincent AL, Ciacci-Zanella JR, Lorusso A, Gauger PC, Zanella EL, Kehrli ME, Jr., Janke BH, and Lager KM: Efficacy of inactivated swine influenza virus vaccines against the 2009A/H1N1 influenza virus in pigs. Vaccine 2010;28:2782-2787
41. Vincent AL, Lager KM, Faaberg KS, Harland M, Zanella EL, Ciacci-Zanella JR, Kehrli ME, Jr., Janke BH, and Klimov A: Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respi Viruses 2010; 4:53-60
42. Vincent AL, Lager KM, Janke BH, Gramer MR, and Richt JA: Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet Microbiol 2008;126:310-323
43. Vincent AL, Lager KM, Ma W, Lekcharoensuk P, Gramer MR, Loiacono C, and Richt JA: Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet Microbiol 2006;118:212-222
44. Vincent AL, Ma W, Lager KM, Gramer MR, Richt JA, and Janke BH: Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 2009;39:176-185
45. Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, Garcia- Sastre A, and Richt JA: Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 2007;25:7999-8009